Gastroenterologie up2date, Table of Contents Gastroenterologie up2date 2013; 9(04): 283-292DOI: 10.1055/s-0033-1344507 Spezielle Themen © Georg Thieme Verlag KG Stuttgart · New YorkDas familiäre Mittelmeerfieber Authors Stephan Paschke Michael Beil Eldad Ben-Chetrit Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) Full Text References Literatur 1 Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351: 659-664 2 Neudorf U, Lainka E, Kallinich T et al. Genetische Fiebersyndrome. Z Rheumatol 2013; 72: 332-338 3 Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the world. Arthritis Rheum 2009; 61: 1447-1453 4 Ozen S, Demirkaya E, Amaryan G et al. Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis 05.03.2013; [Epub ahead of print] 5 Migita K, Uehara R, Nakamura Y et al. Familial Mediterranean fever in Japan. Medicine (Baltimore) 2012; 91: 337-343 6 Ebrahimi-Fakhari D, Schönland SO, Hegenbart U et al. Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk. Scand J Rheumatol 2013; 42: 52-58 7 French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31 8 Grandemange S, Aksentijevich I, Jeru I et al. The regulation of MEFV expression and its role in health and familial Mediterranean fever. Genes Immun 2011; 12: 497-503 9 Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 2009; 146: 467-478 10 Abedat S, Urieli-Shoval S, Shapira E et al. Effect of colchicine and cytokines on MEFV expression and C5a inhibitor activity in human primary fibroblast cultures. Isr Med Assoc J 2002; 4: 7-12 11 Weber A, Wasiliew P, Kracht M. Interleukin-1beta processing pathway. Sci Signal 2010; 3: cm2 12 Ben-Chetrit E, Peleg H, Aamar S et al. The spectrum of MEFV clinical presentations – is it familial Mediterranean fever only?. Rheumatology (Oxford) 2009; 48: 1455-1459 13 Stoffels M, Szperl A, Simon A et al. MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease. Ann Rheum Dis 16.03.2013; [Epub ahead of print] 14 Hesker PR, Nguyen M, Kovarova M et al. Genetic loss of murine pyrin, the Familial Mediterranean Fever protein, increases interleukin-1β levels. PLoS One 2012; 7: e51105 15 Papin S, Cuenin S, Agostini L et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007; 14: 1457-1466 16 Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 2011; 7: 105-112 17 Tunca M, Akar S, Onen F et al. Familial Mediterranean fever (FMF) in Turkey. Medicine (Baltimore) 2005; 84: 1-11 18 Soriano A, Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev 2012; 12: 31-37 19 Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003; 62: 916-919 20 Ben-Zvi I, Livneh A. The Israeli Annual FMF, Amyloidosis and Other Autoinflammatory Diseases Meeting (July 2011). Isr Med Assoc J 2012; 14: 219-220 21 Aksu K, Keser G. Coexistence of vasculitides with familial Mediterranean fever. Rheumatol Int 2011; 31: 1263-1274 22 Deger SM, Ozturk MA, Demirag MD et al. Health-related quality of life and its associations with mood condition in familial Mediterranean fever patients. Rheumatol Int 2011; 31: 623-628 23 Hentgen V, Grateau G, Kone-Paut I et al. Evidence-based recommendations for the practical management of Familial Mediterranean fever. Semin Arthritis Rheum 03.06.2013; [Epub ahead of print] 24 Savic S, Dickie LJ, Wittmann M et al. Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives. Best Pract Res Clin Rheumatol 2012; 26: 505-533 25 Livneh A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-1885 26 Dinarello CA, Wolff SM, Goldfinger SE et al. Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med 1974; 291: 934-937 27 Zemer D, Revach M, Pras M et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 1974; 291: 932-934 28 Ben-Chetrit E, Ozdogan H. Non-response to colchicine in FMF – definition, causes and suggested solutions. Clin Exp Rheumatol 2008; 26: 49-51 29 Ozturk MA, Kanbay M, Kasapoglu B et al. Therapeutic approach to familial Mediterranean fever. Clin Exp Rheumatol 2011; 29: 77-86 30 Soriano A, Verecchia E, Afeltra A et al. IL-1β Biological Treatment of Familial Mediterranean Fever. Clin Rev Allergy Immunol 16.01.2013; [Epub ahead of print]
